Health
Vaccine makers including Moderna must hit US timing goals for full payments – CNA
The United States is tying payments for COVID-19 vaccines to timing milestones for production and approval, according to public documents and a Trump administration official, putting pressure on drugmakers including Moderna Inc to meet ambitious targets.
NEW YORK: The United States is tying payments for COVID-19 vaccines to timing milestones for production and approval, according to public documents and a Trump administration official, putting pressure on drugmakers including Moderna to meet ambitious targets.
In a deal with Moderna announced this week, federal agencies negotiated a sliding scale of payments. The Cambridge, Massachusetts, biotech’s US$1.5-billion deal pays out in full if its vaccine receives regulatory clearance by Jan 31, 2021…
-
Noosa News18 hours agoHow Lily Steele-Park took her rapist to court and won
-
Business23 hours agoFord CEO makes stunning prediction about artificial intelligence
-
General24 hours agoRush to buy homes before rate cuts send prices soaring
-
Business20 hours ago5 things to watch on the ASX 200 on Tuesday 8 July 2025